MARSH IAN ROGER
No ORCID on file
· 45 papers in corpus
· active 2006-2009
Frequent coauthors
- BRADLEY PAUL ANTHONY 45
- DACK KEVIN NEIL 45
- BRADLEY PAUL A 18
- DACK KEVIN N 18
- MARSH IAN R 18
2009
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: R1 represents H, C1-6-alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; R2 represents H, C1-6alkyl (optionally substituted by R3), phenyl (optionally substit…
2009
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: R1 represents H, C1-6-alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; R2 represents H, C1-6alkyl (optionally substituted by R3), phenyl (optionally substit…
2009
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: R1 represents H, C1-6-alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; R2 represents H, C1-6alkyl (optionally substituted by R3), phenyl (optionally substit…
2009
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: R1 represents H, C1-6-alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; R2 represents H, C1-6alkyl (optionally substituted by R3), phenyl (optionally substit…
2009
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: R1 represents H, C1-6-alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; R2 represents H, C1-6alkyl (optionally substituted by R3), phenyl (optionally substit…
2009
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: R1 represents H, C1-6-alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; R2 represents H, C1-6alkyl (optionally substituted by R3), phenyl (optionally substit…
2009
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: R1 represents H, C1-6-alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; R2 represents H, C1-6alkyl (optionally substituted by R3), phenyl (optionally substit…
2009
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: R1 represents H, C1-6-alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; R2 represents H, C1-6alkyl (optionally substituted by R3), phenyl (optionally substit…
2009
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: R1 represents H, C1-6-alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; R2 represents H, C1-6alkyl (optionally substituted by R3), phenyl (optionally substit…
2009
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: R1 represents H, C1-6alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; R2 represents H, C1-6alkyl (optionally substituted by R3), phenyl (optionally substitu…
2009
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: R1 represents H, C1-6alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; R2 represents H, C1-6alkyl (optionally substituted by R3), phenyl (optionally substitu…
2009
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: R1 represents H, C1-6alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; R2 represents H, C1-6alkyl (optionally substituted by R3), phenyl (optionally substitu…
2009
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: R1 represents H, C1-6alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; R2 represents H, C1-6alkyl (optionally substituted by R3), phenyl (optionally substitu…
2009
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: R1 represents H, C1-6alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; R2 represents H, C1-6alkyl (optionally substituted by R3), phenyl (optionally substitu…
2009
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: R1 represents H, C1-6alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; R2 represents H, C1-6alkyl (optionally substituted by R3), phenyl (optionally substitu…
2009
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: R1 represents H, C1-6alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; R2 represents H, C1-6alkyl (optionally substituted by R3), phenyl (optionally substitu…
2009
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: R1 represents H, C1-6alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; R2 represents H, C1-6alkyl (optionally substituted by R3), phenyl (optionally substitu…
2009
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: R1 represents H, C1-6alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; R2 represents H, C1-6alkyl (optionally substituted by R3), phenyl (optionally substitu…
2006
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Rrepresents H, C1-6-alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; Rrepresents H, C1-6alkyl (optionally substituted by R), phenyl (optionally substituted …
2006
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Rrepresents H, C1-6-alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; Rrepresents H, C1-6alkyl (optionally substituted by R), phenyl (optionally substituted …
2006
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Rrepresents H, C1-6-alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; Rrepresents H, C1-6alkyl (optionally substituted by R), phenyl (optionally substituted …
2006
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Rrepresents H, C1-6-alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; Rrepresents H, C1-6alkyl (optionally substituted by R), phenyl (optionally substituted …
2006
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Rrepresents H, C1-6-alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; Rrepresents H, C1-6alkyl (optionally substituted by R), phenyl (optionally substituted …
2006
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Rrepresents H, C1-6-alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; Rrepresents H, C1-6alkyl (optionally substituted by R), phenyl (optionally substituted …
2006
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Rrepresents H, C1-6-alkyl, C1-6alkyloxy, C3-8cycloalkyl, or halo; Rrepresents H, C1-6alkyl (optionally substituted by R), phenyl (optionally substituted …